NCT02245828 A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374 Status COMPLETED Phase PHASE1
NCT02240212 Study of Afuresertib Combined With Paclitaxel in Gastric Cancer Status COMPLETED Phase PHASE1
NCT02236572 Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score Status TERMINATED Phase PHASE2
NCT02233543 A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE4
NCT02232061 Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks Status COMPLETED Phase PHASE4
NCT02229136 Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus Status COMPLETED Phase PHASE2
NCT02228681 Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer Status COMPLETED Phase PHASE2
NCT02228096 Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients Status COMPLETED Phase PHASE2
NCT02226120 Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction Status COMPLETED Phase PHASE3
NCT02221505 Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT02220855 A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas Status COMPLETED Phase PHASE2
NCT02217410 CCFZ533X2201 - PoC Study in de Novo Renal Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT02213042 Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT02205398 Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy Status TERMINATED Phase PHASE1
NCT02204553 Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma Status NO_LONGER_AVAILABLE Phase N/A
NCT02202616 Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study) Status COMPLETED Phase PHASE4
NCT02201290 A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Status COMPLETED Phase PHASE3